Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit

Benjamin Lardinois, Alexandre Dimitriou, Charlotte Delcave, Jacques Jamart, Benoît Bihin, Laura Soumoy, Jean-Daniel Hecq, Laurence M Galanti

Research output: Contribution to journalArticle

Abstract

In some emergency clinical situations, the injection of a more concentrated drug solution in the intensive care units is common. The purpose of this study was to evaluate the physicochemical stability of concentrated solutions of amiodarone hydrochloride in polypropylene syringes during 28 days of storage at 5°C ± 3°C, with protection from light. Five syringes of 50 mL, containing 25 mg/mL of amiodarone in dextrose 5%, were prepared and stored at 5°C ± 3°C with protection from light during 28 days. Immediately after preparation and periodically during the storage, amiodarone hydrochloride concentrations were measured by ultra-performance liquid chromatography. Spectrophotometric absorbance at different wavelengths, pH measurement, and microscopic observations were also performed. All solutions were physicochemically stable during the study period when stored at 5°C ± 3°C. No color change, turbidity, precipitation, opacity, significant pH variations, or optic densities were observed in the solutions. No crystals were seen by microscopic analysis. The concentration of amiodarone did not decrease during the 28 days of storage. Solutions of amiodarone 25 mg/mL in syringes of dextrose 5% are physically and chemically stable for at least 28 days when stored in syringes at 5°C ± 3°C with protection from light and may be prepared in advanced by a centralized intravenous additive service.

Original languageEnglish
Pages (from-to)163-166
Number of pages4
JournalInternational journal of pharmaceutical compounding
Volume23
Issue number2
Publication statusPublished - 16 May 2019

Fingerprint

Amiodarone
Syringes
Intensive Care Units
Light
Glucose
Polypropylenes
Liquid Chromatography
Emergencies
Color
Injections
Pharmaceutical Preparations

Cite this

Lardinois, Benjamin ; Dimitriou, Alexandre ; Delcave, Charlotte ; Jamart, Jacques ; Bihin, Benoît ; Soumoy, Laura ; Hecq, Jean-Daniel ; Galanti, Laurence M. / Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit. In: International journal of pharmaceutical compounding. 2019 ; Vol. 23, No. 2. pp. 163-166.
@article{bc6af641d70b471bb46525075033ced6,
title = "Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit",
abstract = "In some emergency clinical situations, the injection of a more concentrated drug solution in the intensive care units is common. The purpose of this study was to evaluate the physicochemical stability of concentrated solutions of amiodarone hydrochloride in polypropylene syringes during 28 days of storage at 5°C ± 3°C, with protection from light. Five syringes of 50 mL, containing 25 mg/mL of amiodarone in dextrose 5{\%}, were prepared and stored at 5°C ± 3°C with protection from light during 28 days. Immediately after preparation and periodically during the storage, amiodarone hydrochloride concentrations were measured by ultra-performance liquid chromatography. Spectrophotometric absorbance at different wavelengths, pH measurement, and microscopic observations were also performed. All solutions were physicochemically stable during the study period when stored at 5°C ± 3°C. No color change, turbidity, precipitation, opacity, significant pH variations, or optic densities were observed in the solutions. No crystals were seen by microscopic analysis. The concentration of amiodarone did not decrease during the 28 days of storage. Solutions of amiodarone 25 mg/mL in syringes of dextrose 5{\%} are physically and chemically stable for at least 28 days when stored in syringes at 5°C ± 3°C with protection from light and may be prepared in advanced by a centralized intravenous additive service.",
author = "Benjamin Lardinois and Alexandre Dimitriou and Charlotte Delcave and Jacques Jamart and Beno{\^i}t Bihin and Laura Soumoy and Jean-Daniel Hecq and Galanti, {Laurence M}",
note = "Copyright{\circledC} by International Journal of Pharmaceutical Compounding, Inc.",
year = "2019",
month = "5",
day = "16",
language = "English",
volume = "23",
pages = "163--166",
journal = "International journal of pharmaceutical compounding",
issn = "1092-4221",
publisher = "International Journal of Pharmaceutical Compounding",
number = "2",

}

Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit. / Lardinois, Benjamin; Dimitriou, Alexandre; Delcave, Charlotte; Jamart, Jacques; Bihin, Benoît; Soumoy, Laura; Hecq, Jean-Daniel; Galanti, Laurence M.

In: International journal of pharmaceutical compounding, Vol. 23, No. 2, 16.05.2019, p. 163-166.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit

AU - Lardinois, Benjamin

AU - Dimitriou, Alexandre

AU - Delcave, Charlotte

AU - Jamart, Jacques

AU - Bihin, Benoît

AU - Soumoy, Laura

AU - Hecq, Jean-Daniel

AU - Galanti, Laurence M

N1 - Copyright© by International Journal of Pharmaceutical Compounding, Inc.

PY - 2019/5/16

Y1 - 2019/5/16

N2 - In some emergency clinical situations, the injection of a more concentrated drug solution in the intensive care units is common. The purpose of this study was to evaluate the physicochemical stability of concentrated solutions of amiodarone hydrochloride in polypropylene syringes during 28 days of storage at 5°C ± 3°C, with protection from light. Five syringes of 50 mL, containing 25 mg/mL of amiodarone in dextrose 5%, were prepared and stored at 5°C ± 3°C with protection from light during 28 days. Immediately after preparation and periodically during the storage, amiodarone hydrochloride concentrations were measured by ultra-performance liquid chromatography. Spectrophotometric absorbance at different wavelengths, pH measurement, and microscopic observations were also performed. All solutions were physicochemically stable during the study period when stored at 5°C ± 3°C. No color change, turbidity, precipitation, opacity, significant pH variations, or optic densities were observed in the solutions. No crystals were seen by microscopic analysis. The concentration of amiodarone did not decrease during the 28 days of storage. Solutions of amiodarone 25 mg/mL in syringes of dextrose 5% are physically and chemically stable for at least 28 days when stored in syringes at 5°C ± 3°C with protection from light and may be prepared in advanced by a centralized intravenous additive service.

AB - In some emergency clinical situations, the injection of a more concentrated drug solution in the intensive care units is common. The purpose of this study was to evaluate the physicochemical stability of concentrated solutions of amiodarone hydrochloride in polypropylene syringes during 28 days of storage at 5°C ± 3°C, with protection from light. Five syringes of 50 mL, containing 25 mg/mL of amiodarone in dextrose 5%, were prepared and stored at 5°C ± 3°C with protection from light during 28 days. Immediately after preparation and periodically during the storage, amiodarone hydrochloride concentrations were measured by ultra-performance liquid chromatography. Spectrophotometric absorbance at different wavelengths, pH measurement, and microscopic observations were also performed. All solutions were physicochemically stable during the study period when stored at 5°C ± 3°C. No color change, turbidity, precipitation, opacity, significant pH variations, or optic densities were observed in the solutions. No crystals were seen by microscopic analysis. The concentration of amiodarone did not decrease during the 28 days of storage. Solutions of amiodarone 25 mg/mL in syringes of dextrose 5% are physically and chemically stable for at least 28 days when stored in syringes at 5°C ± 3°C with protection from light and may be prepared in advanced by a centralized intravenous additive service.

UR - http://www.scopus.com/inward/record.url?scp=85066836718&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 163

EP - 166

JO - International journal of pharmaceutical compounding

JF - International journal of pharmaceutical compounding

SN - 1092-4221

IS - 2

ER -